RE: demand for e.coli vaccine = ?I, too, do not think any of "Jennifer's" earning estimates are guaranteed. Nor do I think that regulatory approval is a slam dunk. And I think some investors or insiders might also agree. BNC is at a 5 year low and valued at $30 million and this is supposedly prior to imminent (but guaranteed) approval of a animal drug that will sell $1 billion per year? Does not make sense to me. Either the market is nuts and missing a true gem or some investors/insiders have some insight not shared by others. I think investors need to ask:
Is approval really imminent?
Is the market as big as "Jennifer" says?
Are they likely to miss another deadline?
I hope BNC does well and is currently a good value but that seems to be a view point shared by fewer and fewer people. If BNC could do anything to help their embattled shareholders, they should (especially after all the years of broken promises). However, based on their past record, I do not expect much.